000 | 01989 a2200529 4500 | ||
---|---|---|---|
005 | 20250515135954.0 | ||
264 | 0 | _c20081126 | |
008 | 200811s 0 0 eng d | ||
022 | _a1473-558X | ||
024 | 7 |
_a10.1097/WNR.0b013e3283129790 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHorváth, Béla | |
245 | 0 | 0 |
_aCarbon monoxide-prostaglandin E2 interaction in the hypothalamic circulation. _h[electronic resource] |
260 |
_bNeuroreport _cOct 2008 |
||
300 |
_a1601-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xcerebrospinal fluid |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Gas Analysis _xmethods |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCarbon Monoxide _xmetabolism |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aDeuteroporphyrins _xadministration & dosage |
650 | 0 | 4 |
_aDiclofenac _xadministration & dosage |
650 | 0 | 4 |
_aDinoprost _xcerebrospinal fluid |
650 | 0 | 4 |
_aDinoprostone _xcerebrospinal fluid |
650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 |
_aHeme Oxygenase (Decyclizing) _xantagonists & inhibitors |
650 | 0 | 4 |
_aHypothalamus _xblood supply |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xadministration & dosage |
650 | 0 | 4 |
_aProstaglandin D2 _xcerebrospinal fluid |
650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
700 | 1 | _aHortobágyi, László | |
700 | 1 | _aLenzsér, Gábor | |
700 | 1 | _aSchweer, Horst | |
700 | 1 | _aHrabák, András | |
700 | 1 | _aSándor, Péter | |
700 | 1 | _aBenyó, Zoltán | |
773 | 0 |
_tNeuroreport _gvol. 19 _gno. 16 _gp. 1601-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/WNR.0b013e3283129790 _zAvailable from publisher's website |
999 |
_c18282780 _d18282780 |